Skip to main content
Premium Trial:

Request an Annual Quote

Betsy Hanna

Clinical Genomics has appointed Betsy Hanna as its president and CEO. In addition, she will join the firm's board of directors. Hanna succeeds Lawrence LaPointe as CEO, who will transition to the new role of chief innovation officer and serve as an advisor to the board. Hanna previously served as Clinical Genomics' chief commercial officer. Before that, she served as president and COO at Origin. Prior to Origin, Hanna held leadership positions at Johnson & Johnson Diagnostics, where she served as VP, strategic marketing as well as VP Europe, Mideast and Africa. 

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.